Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2023 Aug;43(8):1515-1523.
doi: 10.1007/s00296-023-05313-6. Epub 2023 Apr 18.

Four-factor risk score for the prediction of interstitial lung disease in rheumatoid arthritis

Affiliations
Multicenter Study

Four-factor risk score for the prediction of interstitial lung disease in rheumatoid arthritis

Gouri Mani Koduri et al. Rheumatol Int. 2023 Aug.

Abstract

Objective: Interstitial lung disease (ILD) is one of the commonest systemic complications in patients with rheumatoid arthritis (RA) and carries a significant morbidity and mortality burden. We aimed to identify key variables to risk-stratify RA patients in order to identify those at increased risk of developing ILD. We propose a probability score based on the identification of these variables.

Methods: A retrospective, multicentre study using clinical data collected between 2010 and 2020, across 20 centres.

Results: A total of 430 RA (210 with ILD confirmed on high-resolution computed tomography (HRCT)) patients were evaluated. We explored several independent variables for the risk of developing ILD in RA and found that the key significant variables were smoking (past or present), older age and positive rheumatoid factor/anti-cyclic citrullinated peptide. Multivariate logistic regression models were used to form a scoring system for categorising patients into high and low risk on a scale of 0-9 points and a cut-off score of 5, based on the area under the receiver operating characteristic curve of 0.76 (CI 95% 0.71-0.82). This yielded a sensitivity of 86% and a specificity of 58%. High-risk patients should be considered for investigation with HRCT and monitored closely.

Conclusion: We have proposed a new model for identifying RA patients at risk of developing ILD. This approach identified four simple clinical variables: age, anti-cyclic citrullinated peptide antibodies, Rheumatoid factor and smoking, which allowed development of a predictive scoring system for the presence of ILD in patients with RA.

Keywords: Extra-articular manifestation; Interstitial lung disease; Probability score; Rheumatoid arthritis; Risk prediction.

PubMed Disclaimer

Conflict of interest statement

The authors have declared no conflicts of interest.

Figures

Fig. 1
Fig. 1
Receiver operating characteristic curve of the risk scores (the ROC area (95% CI) 0.76 (0.71–0.82). A value of 5 points (with the sign of the cross) showed a sensitivity of 86% and a specificity of 58%. The point was chosen based on the optimal sensitivity and specificity

Similar articles

Cited by

References

    1. Turesson C, O’Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis. 2003;62:722–727. doi: 10.1136/ard.62.8.722. - DOI - PMC - PubMed
    1. Olson AL, Swigris JJ, Sprunger DB, Fischer A, Fernandez-Perez ER, et al. Rheumatoid arthritis-interstitial lung disease-associated mortality. Am J Respir Crit Care Med. 2011;183:372–378. doi: 10.1164/rccm.201004-0622OC. - DOI - PMC - PubMed
    1. Habib HM, Eisa AA, Arafat WR, Marie MA. Pulmonary involvement in early rheumatoid arthritis patients. Clin Rheumatol. 2011;30:217–222. doi: 10.1007/s10067-010-1492-5. - DOI - PubMed
    1. O’Dwyer DN, Armstrong ME, Cooke G, Dodd JD, Veale DJ, Donnelly SC. Rheumatoid arthritis (RA) associated interstitial lung disease (ILD) Eur J Intern Med. 2013;24:597–603. doi: 10.1016/j.ejim.2013.07.004. - DOI - PubMed
    1. Shaw M, Collins BF, Ho LA, Raghu G. Rheumatoid arthritis-associated lung disease. Eur Respir Rev. 2015;24:1–16. doi: 10.1183/09059180.00008014. - DOI - PMC - PubMed

Substances